Skip to main navigation
Neuropace
Neuropace
  • Overview
  • Stock Information
    • Stock Quote & Chart
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Financial Information
    • SEC Filings
  • Governance
    • Governance Overview
    • Management
    • Board of Directors
    • Committee Composition
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

News Releases

Mar 02, 2023
NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
MOUNTAIN VIEW, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the fourth quarter and full-year ended December 31, 2022.
PDF Version
Feb 10, 2023
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
MOUNTAIN VIEW, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year of 2022 after
PDF Version
Jan 09, 2023
NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of Directors
MOUNTAIN VIEW, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced preliminary, unaudited revenue results for the fourth quarter and full-year ended
PDF Version

Shareholder Tools

  • Copyright © 2023 Neuropace

Footer Legal

  • Legal
  • Privacy Policy